InsiderTrades

Form 4 for MLKN MILLERKNOLL, INC.

Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001869938-25-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-17 2025-01-15 MLKN Smith Michael R Dir M - OptEx $21.90 +508.33 1,793 +40% +$11.1K
D 2025-01-17 2025-01-15 MLKN Smith Michael R Dir J - Other $21.90 -0.33 1,793 -0.0% -$7.23
DM 2025-01-17 2025-01-15 MLKN Smith Michael R Dir A - Grant $6.11 +13.7K 9,905 New +$84.0K
D 2025-01-17 2025-01-15 MLKN Smith Michael R Dir M - OptEx $21.90 -508.33 19.2K -3% -$11.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-15 M A 508.33 $21.90 1,793.33 D — —
2 Common Common Stock 2025-01-15 J D 0.33 $21.90 1,793 D — —
3 Derivative Phantom Stock 2025-01-15 A A 3,835.62 $21.90 19,756.15 D — · — to — 3,835.62 Common Stock (F4) The Number of Derivative Securities Beneficially Owned reflected in Table II of this form include shares acquired through participation in the MillerKnoll, Inc. Director Deferred Compensation Plan, which satisfies the exemption of Rule 16b-3. (F3) Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan.
4 Derivative Phantom Stock 2025-01-15 M D 508.33 $21.90 19,247.82 D — · 2025-01-15 to — 508.33 Common Stock (F3) Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in shares of common stock, at the election of the reporting person made in accordance with the company's director deferred compensation plan.
5 Derivative Non-Qualified Stock Option (right to buy) 2025-01-15 A A 9,905 $0.00 9,905 D $21.90 · — to 2035-01-15 9,905 Common Stock (F2) This grant is fully vested on date of grant.